Nasohist - 63717-325-30 - (Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride)

Alphabetical Index


Drug Information of Nasohist

Product NDC: 63717-325
Proprietary Name: Nasohist
Non Proprietary Name: Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
Active Ingredient(s): 1; 3; 2    mg/mL; mg/mL; mg/mL & nbsp;   Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Nasohist

Product NDC: 63717-325
Labeler Name: Hawthorn Pharmaceuticals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20110609

Package Information of Nasohist

Package NDC: 63717-325-30
Package Description: 1 BOTTLE in 1 CARTON (63717-325-30) > 30 mL in 1 BOTTLE

NDC Information of Nasohist

NDC Code 63717-325-30
Proprietary Name Nasohist
Package Description 1 BOTTLE in 1 CARTON (63717-325-30) > 30 mL in 1 BOTTLE
Product NDC 63717-325
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20110609
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Hawthorn Pharmaceuticals, Inc.
Substance Name CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 1; 3; 2
Strength Unit mg/mL; mg/mL; mg/mL
Pharmaceutical Classes

Complete Information of Nasohist


General Information